远程缺血调理治疗脓毒性休克:RECO-Sepsis随机临床试验
RECO-Sepsis是一项在法国6个ICU开展的前瞻性、多中心、随机、开放标签、平行组、结局评估盲法的临床试验,纳入成人脓毒性休克患者,在休克发生12小时内按1:1随机接受RECO(袖带200/0 mmHg充气/放气各5分钟,共4次,每12小时一次,持续24小时)或假操作。主要终点为入组至第4天日均SOFA评分,RECO组与对照组无显著差异(7.2分[5.2-10.7] vs 7.6分[4.9-10.7],p=0.919)。90天累积死亡率RECO组27.6% vs 对照组39.6%(Log-rank检验p=0.10;校正HR 0.59,95%CI 0.35-0.99;p=0.049)。结论认为RECO未能减轻器官衰竭严重程度,需要足够把握度的试验评估其可能的延迟获益。
要点
- 脓毒性休克发生12小时内启动RECO(袖带200/0 mmHg充气/放气各5分钟,共4次,每12小时一次,持续24小时)未能降低入组至第4天日均SOFA评分(7.2分[5.2-10.7] vs 7.6分[4.9-10.7],p=0.919)。
- 90天累积死亡率RECO组27.6% vs 对照组39.6%,Log-rank检验p=0.10,差异未达统计学显著。
- 校正后HR 0.59(95%CI 0.35-0.99,p=0.049),提示RECO可能带来延迟获益,但原文结论强调需足够把握度的试验进一步评估。
- 本研究为前瞻性、多中心、随机、开放标签、平行组、结局评估盲法试验,共180例随机、178例纳入意向性治疗分析(RECO组87例,对照组91例)。
适用人群与场景
- 法国6个ICU的成人脓毒性休克患者,在脓毒性休克发生12小时内随机分组。
- 180例随机,178例完成试验并纳入意向性治疗分析(RECO组87例,对照组91例;108例男性[60.7%],中位年龄68[59-75]岁)。
处置流程与药物剂量
- RECO组:袖带置于手臂,充气/放气(200/0 mmHg,各5分钟)共4次,每12小时一次,持续24小时。
- 对照组:接受假操作,每12小时一次,持续24小时。
研究设计与关键结果
- 研究类型:前瞻性、多中心、随机、开放标签、平行组、结局评估盲法临床试验,在法国6个ICU开展,随访90天。
- 主要终点:入组至第4天日均SOFA评分,RECO组7.2分[5.2-10.7] vs 对照组7.6分[4.9-10.7],p=0.919,无显著差异。
- 90天累积死亡率:RECO组27.6% vs 对照组39.6%(Log-rank检验p=0.10;校正HR 0.59,95%CI 0.35-0.99;p=0.049)。
证据类型、等级与局限
- 证据类型:随机对照试验(RCT)。
- 局限:原文未报告局限性。
对床旁实践的改变
- 本研究显示,在脓毒性休克发生12小时内启动RECO(200/0 mmHg,充气/放气各5分钟,共4次,每12小时一次,持续24小时)未能降低入组至第4天日均SOFA评分。
- 作者认为,需要足够把握度的试验评估RECO可能的延迟获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: To determine whether remote ischemic conditioning (RECO), compared to standard care, limits the severity and the consequences of multiple organ failure in patients with septic shock.
METHODS: The RECO-Sepsis trial, a prospective, multicenter, randomized, open-label, parallel group trial with blinded assessment of the outcome, was conducted at six intensive care units in France in adult patients with septic shock. Within 12 h after the onset of septic shock, patients were randomized (1:1 ratio) to receive either RECO applied by inflating/deflating (200/0 mmHg for 5/5 min) 4 times a cuff around an arm or a sham procedure every 12 h for 24 h. The primary endpoint was the severity of multiple organ failure assessed by the mean daily Sequential Organ Failure Assessment (SOFA) score from inclusion to the fourth day after inclusion (day 4). Patients were followed for 90 days.
RESULTS: Among 180 randomized patients, 178 completed the trial (RECO group: 87; control group: 91) and were included in the intention-to-treat analysis (108 men [60.7%], median age 68 [59-75] years). There was no significant difference in the mean daily SOFA score between the intervention group and the control group (7.2 points [5.2-10.7] versus 7.6 points [4.9-10.7], respectively; p = 0.919). Cumulative mortality within 90 days was 27.6% in the RECO group and 39.6% control group (Log-rank test, p = 0.10; adjusted hazard ratio 0.59, 95% CI, 0.35 to 0.99; p = 0.049).
CONCLUSIONS: In patients with septic shock, RECO failed to reduce the severity of organ failures assessed by mean daily SOFA score from inclusion to day 4. Adequately powered trials are needed to assess potential delayed benefits of RECO.
参考来源
- Cour M, Klouche K, Souweine B, et al. Remote ischemic conditioning in septic shock: the RECO-Sepsis randomized clinical trial. Intensive Care Med. 2022. PMID: 36100725. doi:10.1007/s00134-022-06872-1
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。